While aminosalicylates (5-ASAs), biologic therapies and immunomodulator medications are widely used for the treatment of inflammatory bowel disease (IBD), few clinicians have a comprehensive understanding of the pharmacologic underpinnings that make these treatments so effective.
Available on-demand through AGA University, Advanced Practice Provider Pharmacology: IBD is a two-hour course for clinicians of all background levels that presents complex technical information in five easy-to-understand modules.
Course faculty includes: Kimberly Kearns, MS, APRN, ANP-BC (Chair); Erin Darguzas, MSN, APN; and Shawna Sullivan, MSN, APRN, ACNP-BC.
Complete this course by July 31, 2020 and receive 2 AMA PRA Category 1 Credits™ or 2 AANP pharmacology contact hours.
This program is made possible by support from Gilead Sciences, Inc. and Takeda Pharmaceuticals U.S.A., Inc.